Veradermics Inc.
PrivateLast Round
Early Stage
VC
May 15, 2026
Est. Valuation
$596.3M
Total Funding Raised
$245.7M
Momentum Score
100 /100
Company Overview
Veradermics Inc. is a biopharmaceutical company developing first-in-class therapeutics for common dermatologic conditions such as pattern hair loss, common warts, and molluscum contagiosum.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Devices
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Veradermics Inc. Comps
Public and private peers based on sector, stage, and business model.
Veradermics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | May 15, 2026 | ||||
| IPO Announced | Feb 3, 2026 | ||||
| Series C | Oct 16, 2025 | ||||
| Series B | Dec 11, 2024 | ||||
| Series A | Sep 22, 2021 |
Key People
Founding team and executive leadership
Veradermics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jefferies | IPO |
| Longitude Capital | Series B, Series C |
| Surveyor Capital | Series C |
| Connecticut Innovations | Series B, Series A |
| LifeSci Venture Partners | Series C |
| abrdn Inc. | Series C |
| Columbia Threadneedle Investments | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2026
Open roles increased to 7, 2.5x the trailing average.
- May 15, 2026
Raised $30M in an early stage VC round.
Veradermics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Veradermics Inc.'s valuation, stock price, and market status.